c-LEcta expands framework supply agreement

c-LEcta announces the signing of an amendment of a framework supply agreement with one of the world’s TOP 10 pharma companies. It expands the long...

read more


c-LEcta partners in a consortium led by DSM for the development of enzymatic oxidative processes

c-LEcta is proud to announce its partnership in “ROBOX”, a EU Horizon 2020 granted project (grant agreement n° 635734), which aims at expanding the...

read more


c LEcta presents new Corporate Design

c‑LEcta today introduces its new corporate design. The relaunched company website reflects c‑LEcta transformation over the last 10 years from an R&D...

read more


c-LEcta expands management

Harry Böhme joins c-LEcta’s management team as CFO and managing director. In his previous position, Harry was CFO at Novaled AG in Dresden and as such...

read more


c-LEcta Plug & Play Biocats™ – the pathfinder of enzyme catalysis in API synthesis

The great potential of enzymes in the syntheses of chiral molecules, especially small molecule APIs, has not been fully exploited yet. The main...

read more


c-LEcta closes successful business year 2014

In 2014 c-LEcta closed another successful business year and continues its growth path. With an annual revenue growth of 33% and an overall positive...

read more


European Patent Office grants patent on c-LEcta’s Asparaginase

c-LEcta has been granted a European patent protecting the company’s thermoactive asparaginase (EP2193198B1). Asparaginases are used as food...

read more


c-LEcta enzyme provides the missing link in a flavor compound synthesis

In a recent article which was published in ChemCatChem1, the ADH-collection of c-LEcta could provide the missing link to enable a two-enzyme cascade...

read more


c-LEcta receives patent on Nitrilases

c-Lecta has been granted a new patent by the US Patent and Trademark Office protecting the company’s nitrilase enzyme platform (US 8,916,364)....

read more